Ritonavir Package Insert

ON LOPINAVIR AND RITONAVIR (LPV/R) ORAL PELLETS
Fact sheet on lopinavir and ritonavir (lpv/r) oral pellets Adapted from Cipla package insert approved by USFDA and WHO 2013 dosages of recommended antiretroviral drugs 3-4.9kg 6 ... Access Content

Grazoprevir - Wikipedia
Grazoprevir is a drug approved for the treatment of hepatitis C. It was developed by Merck and completed Phase III trials, used in combination with the NS5A replication complex inhibitor elbasvir under the trade name Zepatier, either with or without ribavirin. ... Read Article

Save Up To BILL PRIM ARY INSURANCE FIRST INSURED PATIENTS ...
NORVIR® (ritonavir) oral powder is a prescription medicine that is used with other antiviral medicines to treat children with HIV-1 infection. HIV-1 is the virus that causes AIDS (Acquired Immune Deficiency Syndrome). NORVIR [package insert]. North Chicago, IL: AbbVie Inc. ... Read Document

HIGHLIGHTS OF PRESCRIBING INFORMATION OPSUMIT
See full prescribing information for complete boxed warning • Do not administer OPSUMIT to a pregnant female because it may cause fetal harm (4.1, 5.1, Strong CYP3A4 inhibitors (ketoconazole, ritonavir)increase exposure to macitentan: avoid co-administration with OPSUMIT (7.2, 12.3). ... Read Full Source

HIGHLIGHTS OF PRESCRIBING INFORMATION Such Dose Adjustments ...
TYBOST is not interchangeable with ritonavir to increase systemic exposure of darunavir 600 mg twice daily, or elvitegravir fosamprenavir, saquinavir, or tipranavir due to lack of exposure data. The use of TYBOST is not recommended with darunavir 600 mg twice daily, fosamprenavir, saquinavir, or tipranavir. (5.4) ... Return Document

Hepatic Impairment: Discontinue For Signs And Symptoms Of ...
APTIVUS, co-administered with ritonavir, is indicated for combination antiretroviral treatment of HIV-1 infected patients who a re treatment-experienced and infected with HIV-1 strains resistant to more than one protease inhibitor (PI). ... Access Full Source

Reference ID: 3986032 - Food And Drug Administration
Ritonavir is required with several REYATAZ dosage regimens (see the ritonavir . Reference ID: 3986032 3 . complete prescribing information about the safe and effective use of ritonavir). The use of REYATAZ in treatment-experienced adult patients without ritonavir is not recommended. ... Retrieve Here

Efavirenz/emtricitabine/tenofovir - Wikipedia
Efavirenz/emtricitabine/tenofovir was approved for medical use in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is about US$10.71–14.19 per month as of 2014. ... Read Article

HIGHLIGHTS OF PRESCRIBING INFORMATION When Cobicistat, A ...
For use with ritonavir or products containing ritonavir, or in combination with other antiretroviral drugs that require CYP3A inhibition to achieve adequate exposures (e.g., other protease inhibitors and elvitegravir). FULL PRESCRIBING INFORMATION . 1 INDICATIONS AND USAGE . ... View Document

HIGHLIGHTS OF PRESCRIBING INFORMATION ...
• Ritonavir should be taken at the same time as INVIRASE. • INVIRASE and ritonavir should be taken within 2 hours after a meal. • For patients already taking ritonavir 100 mg twice daily as part of their antiretroviral regimen, no additional ritonavir is needed. ... Document Retrieval

IMPORTANT DRUG WARNING - Genentech
Ritonavir is manufactured by Abbott Laboratories; please see the Norvir ® (ritonavir) package insert for additional risk information specifically related to ritonavir. *The term “ saquinavir soft gel capsules” refers to a drug product, no longer available, that was marketed as ... Read Document

CO-ADMINISTRATION OF NORVIR WITH CERTAIN NONSEDATING ...
Ritonavir is a peptidomimetic inhibitor of both the HIV-1 and HIV-2 proteases. Inhibition of HIV protease renders the enzyme incapable of processing the gag-pol polyprotein precursor which leads to production of non-infectious immature HIV ... Access Doc

Ritonavir (Norvir, RTV) - AIDSinfo
Ritonavir during pregnancy than postpartum.2 Ritonavir concentrations are also reduced during pregnancy versus postpartum when the drug is used at a low dose (100 mg) to boost the concentrations of other protease Ritonavir [package insert]. Food and Drug Administration. 2015. Available at ... Access Content

Pravastatin - Wikipedia
Pravastatin (marketed as Pravachol or Selektine) is a member of the drug class of statins, used in combination with diet, exercise, and weight loss for lowering cholesterol and preventing cardiovascular disease. ... Read Article

Ombitasvir, Paritaprevir/ritonavir Plus Dasabuvir (Viekira Pak
Ombitasvir, paritaprevir/ritonavir plus dasabuvir with or without ribavirin with or without ribavirin achieved SVRs in the range of 95-100%. In addition, ombitasvir, paritaprevir/ritonavir plus dasabuvir with ribavirin were evaluated in HCV genotype patients with liver transplant and patients co-infected with HIV. ... Fetch Here

HIGHLIGHTS OF PRESCRIBING INFORMATION Prescribing Information ...
Necrolysis (TEN) or Stevens-Johnson syndrome) to ritonavir or any of its ingredients. • NORVIR is contraindicated with drugs that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening reactions. ... Get Document

KALETRA (lopinavir and ritonavir) tablet, for oral use KALETRA (lopinavir and ritonavir) oral solution Initial U.S. Approval: 2000 INDICATIONS AND USAGE KALETRA is an HIV-1 protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients(14 days and older). (1) ... Fetch Here

HIGHLIGHTS OF PRESCRIBING INFORMATION Preexisting Conduction ...
Ritonavir when given concomitantly with other antiretroviral drugs and H. 2-receptor antagonists (H2RA). Ritonavir is required with several REYATAZ dosage regimens (see the ritonavir complete prescribing information about the safe and effective use of ritonavir). The use of ... Doc Viewer

HIGHLIGHTS OF PRESCRIBING INFORMATION Co-administration With ...
Optional alternative is to insert the ring using the applicator for NuvaRing [see Applicatorfor NuvaRing Instructions for Use].The exact position of NuvaRing inside the vagina is not critical for its function. The vaginal ring must be inserted on the appropriate day and left in place for three consecutive weeks. This ... Retrieve Document